Reach Us +1-217-403-9671
A Novel Drug Delivery System: Insulin Free Needle Injection Technology | 7570
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

A novel drug delivery system: Insulin free needle injection technology

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

Sanjay Reddy Akula and Jyothi Edla

Accepted Abstracts: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.008

Diabetes mellitus is chronic, progressive systemic disease characterized by dysfunction insulin function. Physiological resistance to self injection or needle phobia has been seen across many populations in treatment of diabetes and require injectable products two or three times a day. A series of discoveries led to the development of the hypodermic needle which underwent significant changes. To overcome the problems related to needle based injections in treatment of diabetes there is one technology NFIT (Needle freed injectable technology).Needle free delivery is done conveniently both for solids and liquids. Various needle free injectors are available in the market like Biojector, vitajet, iject, etc. These formulations are designed for better acceptability and patient convenience. They offer less pain and no needle phobia. They are ideally suited to chronic injections of varying doses of insulin, proteins and monoclonal antibodies. And other novel drug formulations for diabetic patients i.e. insulin micro pump, insulin transdermal patches, insulin nanopump, insulin pen, insulin tablets, insulin capsules, insulin spray, inhalable insulin.